Girard Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-64,817
Closed -$722K 266
2022
Q4
$722K Sell
64,817
-462
-0.7% -$5.37K 0.08% 166
2022
Q3
$774K Buy
65,279
+10,003
+18% +$152K 0.1% 143
2022
Q2
$844K Buy
55,276
+8,198
+17% +$147K 0.11% 134
2022
Q1
$995K Buy
47,078
+13,413
+40% +$289K 0.11% 136
2021
Q4
$795K Buy
33,665
+11,969
+55% +$256K 0.09% 143
2021
Q3
$435K Buy
+21,696
New +$445K 0.05% 167
2018
Q4
Sell
-2,000
Closed -$29K 579
2018
Q3
$29K Buy
+2,000
New +$29.2K 0.01% 538

Other funds holding MPT

Girard Partners's MPT Position: Q1 2023 in Review

Girard Partners sold out of Medical Properties Trust (MPT) in Q1 2023, closing a stake of 64,817 shares — an estimated $722K sold.

Girard Partners first reported a position in MPT in Q3 2018 and held it in 7 quarters. The position peaked at $995K in Q1 2022. 629 funds tracked by Wall St. Rank hold MPT as of Q1 2023.

  • Girard Partners reported no remaining Medical Properties Trust position as of Q1 2023 after selling out during the quarter.
  • Girard Partners sold 64,817 Medical Properties Trust shares in Q1 2023, an estimated $722K.
  • Girard Partners first reported a position in Medical Properties Trust in Q3 2018 and held it in 7 quarters.
  • Girard Partners's Medical Properties Trust position peaked at $995K in Q1 2022.
  • 629 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2023.

Based on Girard Partners's 13F filing for Q1 2023, filed 12 May 2023.